Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Japanese Journal of Clinical Oncology|April 1, 1992
Invasive ductal carcinoma of the breast with a predominant intraductal component: cooperative clinicopathologic study in seven Japanese centersM Enjoji, A Matsukuma, G Sakamoto, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1990
In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cellsS Mori, Y Mori, T Mukaiyama, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in JapanT Ishida, T Yokoe, F Kasumi, et al.
Histopathology|July 29, 2008
Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS casesT Kawasaki, S Nakamura, G Sakamoto, et al.
Cancer|September 1, 1984
Histologic review of breast cancer cases in survivors of atomic bombs in Hiroshima and Nagasaki, JapanS Tokuoka, M Asano, T Yamamoto, et al.
Cancer Letters|September 30, 1999
Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instabilityK Minobe, K Bando, K Fukino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancerA Hirano, M Emi, M Tsuneizumi, et al.
Histopathology|April 24, 2007
Expression of oestrogen receptor-beta in apocrine carcinomas of the breastN Honma, K Takubo, F Akiyama, et al.
Breast Cancer (Tokyo, Japan)|January 16, 2002
Evaluation of HER2 status: for the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab)S Umemura, G Sakamoto, H Sasano, et al.
Japanese Journal of Cancer Research : Gann|November 21, 2001
Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasisS Haga, M Emi, A Hirano, et al.
Pageof 10